The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...
Oprah Winfrey is sparking a debate around weight, willpower and perception after the media mogul revealed her perceptions ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
The healthcare industry experienced a rollercoaster of a year in 2024, with pharmacy benefits undergoing significant shifts.
Colorado plans to start limiting insurance coverage of prescription weight-loss drugs for its roughly 40,000 state employees, a cost-cutting measure in a difficult budget year that officials say will ...
A new report finds half of adults in the United States could be eligible for popular weight loss drugs. KYW medical editor Dr ...
Scientists may have discovered a way to naturally regulate blood sugar levels and sugar cravings that works similarly to ...